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A number of secondary plant metabolites (e.g., flavonoids) possess
antiviral/antimicrobial activity. Most flavonoids, however, are difficult to study, as they
are immiscible in water-based systems. The relatively new semisynthetic α-glucosyl
hesperitin (GH), and the natural plant product epigallocatechin gallate (EGCG) are
unique among most flavonoids, as these flavonoids are highly soluble. The antiviral
activity of these plant metabolites were investigated using the rotavirus as a model
enteric virus system. Direct loss of virus structural integrity in cell-free suspension and
titration of amplified RTV in host cell cultures was measured by a quantitative enzyme-
linked immunosorbent assay (qEIA). After 30 min. 100 × 103 μg/ml GH reduced RTV
antigen levels by ca. 90%. The same compound reduced infectivity (replication in cell
culture) by a similar order of magnitude 3 to 4 days post inoculation. After 3 days
in culture, EGCG concentrations of 80, 160, and 320 μg/ml reduced RTV infectivity
titer levels to ca. 50, 20, and 15% of the control, respectively. Loss of RTV infectivity
titers occurred following viral treatment by parallel testing of both GH and EGCG, with
the latter, markedly more effective. Cytotoxicity testing showed no adverse effects
by the phenolic concentrations used in this study. The unique chemical structure of
each flavonoid rather than each phenolic’s inherent solubility may be ascribed to those
marked differences between each molecule’s antiviral (anti-RTV) effects. The solubility of
EGCG and GH obviated our need to use potentially confounding or obfuscating carrier
molecules (e.g., methanol, ethanol, DMSO) denoting our use of a pure system environ.
Our work further denotes the need to address the unique chemical nature of secondary
plant metabolites before any broad generalizations in flavonoid (antiviral) activity may be
proposed.
Keywords: rotavirus, infectivity titers, a-glucosyl hesperidin, epigallocatechin gallate, ELISA
Introduction
Reports have linked the consumption of selected plant juices (e.g., cranberry, grape) and
green tea to numerous broad-based health beneﬁts. Such health-promoting eﬀects have
been traced to certain secondary plant metabolites within these plant species, including
proanthocyanidins of berries and grapes, and epigallocatechin gallate (EGCG) of green tea
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(Higdon and Frei, 2003; Aron and Kennedy, 2008; Bose et al.,
2008; Xiao et al., 2011). Among those numerous health pro-
moting eﬀects proposed from the consumption of comestible
plant products, antimicrobial activity has been the subject of an
increasing number of substantive reports over the last one or two
decades. Whether on a descriptive or mechanistic approach, in
vitro and in vivo studies have proposed that ﬂavonoids (phenol-
based secondary plant metabolites (Thilakarathna and Vasantha
Rupasinghe, 2013) impart antimicrobial activity among a wide
range of infectious agents including but not necessarily limited to
bacteria (viz., Escherichia coli-associated urinary tract infections),
viruses (e.g., Herpes Simplex Virus, Human Immunodeﬁciency
Virus, Respiratory Syncytial Virus, Hepatitis C virus, Reovirus,
Rotavirus, Enteroviruses,), and parasites (Entamoeba histolytica,
Giardia lamblia; Mukoyama et al., 1991; Nagi et al., 1992; Calzada
et al., 2001; Nair et al., 2002; Mim and Hart, 2003; Suzutani
et al., 2003; Lu et al., 2004; Zakay-Rones et al., 2004; Song
et al., 2005; Mukhtar et al., 2008; Guay, 2009; Kim et al., 2010;
Lipson et al., 2010; Gescher et al., 2011; Roh and Jo, 2011;
Thapa et al., 2012). Most ﬂavonoids, however, are immiscible
in water and therefore, require carrier organic solvents [e.g.,
methanol, ethanol, dimethylsulfoxide (DMSO)] to bring such
secondary plant metabolites into solution. Dilution of solubi-
lized stock ﬂavonoid preparations to working strength concen-
trations (e.g., in the preparation of dose-response curves) in cell
culture maintenance medium (MM), phosphate-buﬀered saline
(PBS), or other water-based systems, induces a solute precipi-
tation and/or one must maintain a high solvent concentration
potentially aﬀecting overt or subtle cytotoxic eﬀects (see Lipson
et al., 2013). As alluded to by others, the low water solubility
of ﬂavonoids in general, has limited the use of such secondary
plant metabolites in basic and biomedical research (Yamada et al.,
2006; Saha et al., 2009). A need exists to evaluate water soluble
ﬂavonoid extracts for the purpose of identifying new comestible
plant products with potential antiviral activity. The semisyn-
thetic α-glucosyl hesperidin (GH) or more commonly termed
GH (Hijiya and Miyake, 1999), is an extremely soluble semi-
synthetic ﬂavanone of citrus fruit species, promoting a solubility
in water ca. 10,000 times that of hesperidin per se (Yamada
et al., 2006; Saha et al., 2009). Although GH was originally for-
mulated for use as a cosmetic to improve skin circulation and
tone (Lanzendorfer et al., 1999; Hou et al., 2012), this product
was shown to have an inhibitory eﬀect on the in vitro replica-
tion of inﬂuenza virus, expounding upon the chemical’s marked
solubility (Saha et al., 2009). The testing and potential use of
ﬂavonoids as antiviral moieties from comestible plant species is
supported by an absence of data suggesting any mutagenic activ-
ity. One should further point out that despite the availability
of RTV vaccines, the “take” is not absolute. Species within the
Genus Rotavirus (Family Reoviridae) accordingly, remain a sig-
niﬁcant etiologic agent of morbidity and mortality, especially in
the Third World. The purpose of this study therefore was to eval-
uate the eﬃcacy of semisynthetic ﬂavonoid GH, as an antiviral
secondary plant metabolite using the environmentally signiﬁ-
cant rotavirus as a model system. In complement with this work,
the anti-rotavirus activity of GH was compared where appropri-
ate, to the well-studied and characterized EGCG of green tea,
through the determination of changes in RTV infectivity titers
in African Green monkey kidney epithelial (MA-104) host cell
cultures.
Materials and Methods
Virus, Cell Culture, and Infectivity Testing
The simian rotavirus strain SA-11 (RTV; ATCC VR-1565) was
used in this study. Infectivity titration measurements were per-
formed to quantitate the number of infectious RTV particles
present in our system following treatment with GH and/or
EGCG. Cell growth and maintenance were performed according
to standard procedures (Lipson, 1992). Brieﬂy, host cells con-
sisted of African green monkey kidney epithelial (MA-104) cells,
clone Cercopithecus aethiop (ATCC CRL-2378.1) were grown
to conﬂuency in 96-well ﬂat bottom microtiter plates. Growth
medium (GM) consisting of Eagle’s minimal essential medium
supplemented with 10% fetal bovine serum (FBS), 100 μg/ml
streptomycin, 100 units penicillin, 1% L-glutamine, and 1%
amphotericin B. Maintenance medium (MM) was the same as
GM except that 2% FBS was used as a medium supplement. Prior
to virus inoculation, the GM was removed by aspiration, with
MM added to each well.
The infectivity titer of RTV stock was determined by end-
point dilution and expressed as tissue culture infective dose-ﬁfty
(TCID50)/ml (Reed and Muench, 1938). The virus was frozen at
−70◦C in aliquot preparations until use.
Secondary Plant Metabolites
The secondary plant metabolites (–)-EGCG of Camellia sinen-
sis (“Tea catechin”) was purchased from Cayman Chemical Co.,
Chicago, IL, USA. α-GH was kindly supplied by Hayashibara
Co. Ltd. (Okayama, Japan). Stock concentrations of GH were
prepared in Dulbecco’s PBS modiﬁed without calcium and with-
out magnesium (Sigma-Aldrich, Saint Louis, MO, USA), and
used immediately. For EGCG, 1 ml of the DPBS was added to
manufacturer-supplied screw capped glass vials containing 50mg
of the catechin, inverted numerous times to aﬀect placement of
the metabolite into solution, used immediately, or placed for 2–
3 days at refrigeration temperature (4◦C) until use (Zhou et al.,
2003). Dilution of the GH and EGCG to working strength con-
centrations coupled with the presence of antibiotics/antimycotic
supplements in the cell culture MM, precluded any subsequent
bacterial/fungal contamination.
Experimental Protocols
Anti-RTV activity was evaluated by direct specimen testing in
cell-free suspension, and by changes in viral infectivity titers in
M-104 cells cultures.
Direct Specimen Testing
Direct specimen testing was performed to identify the eﬀect of
GH on the loss of RTV capsid antigen integrity in cell-free suspen-
sion. Brieﬂy, equal volumes of virus stock suspension (3.1 × 104
TCID50/ml; Figure 2) and PBS containing increasing concentra-
tions of GH were incubated for 5 or 30 min. at room temperature
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(23◦C) followed by direct testing for the presence of viral cap-
sid protein. The positive control consisted of the RTV plus and
equal volume of PBS. The negative control consisted of PBS,
alone. Direct specimen testing (i.e., used in the current work for
the testing of viral capsid function and as an antigenic determi-
nant) in cell-free suspension was measured through the use of a
quantitative antigen capture [capsid protein VP6 (VP6)] enzyme-
linked immunosorbent assay [PremierTM Rotaclone
R©
Enzyme-
Linked Immunosorbent Assay, qEIA; (Meridian Diagnostics,
Cincinnati, OH, USA)]. Quantitative EIA signals, reﬂective of
changes in viral capsid antigen levels and presented on dose
response curves, were objectively measured employing a Genesys
20 spectrophotometer (ThermoFisher, Inc., Waltham, MA, USA)
at a wavelength of 450 lambda as per manufacturer’s speciﬁca-
tions (Package Insert, Meridian). All testing was performed in
triplicate. Developed in the 1980s, the rotavirus antigen cap-
ture EIA, has since been used as a sensitive and speciﬁc system
by medical laboratory personnel and infectious disease special-
ists for the monitoring of viral antigen as well as RTV (Type
A) clinical disease, respectively, (Cukor et al., 1984; Stals et al.,
1984; Knowlton et al., 1991; Dornai et al., 1993; Raj et al., 2007;
Fang et al., 2009; Tran et al., 2010; Lipson et al., 2011; Gautam
et al., 2013; Sai et al., 2013; Lipson, Personal observation). The
RTV antigen capture EIA, as well as most other antigen/antibody
capture EAI systems, may readily be exploited in a quantita-
tive manner as performed in the current study (see EDVOTEK,
2011).
Antigen Detection – Cell Culture Amplification
The technique of antigen detection – cell culture ampliﬁcation
(Ag-CCA) technology was used as a methodology to measure
changes in viral infectivity titers. Brieﬂy, RTV infectivity titers
were performed using MA-104 (host) cells grown to monolayer
cultures in 96-well microtiter cluster plates (Figure 1). Equal
volumes of RTV stock suspensions (3.1 × 103 and 3.1 × 014
TCID50/ml and PBS containing 100 × 103 μg/ml GH were
inoculated (25 μl) onto 96-well microtiter plates containing MA-
104 (host) cells cultures. The cells cultures were incubated for
a period of 120 h (5 days) at 37◦C in 5% CO2. Detection of
the presence (or absence) of RTV antigen virus replication as
a factor of time, was measured by the qEIA. Objective mea-
surements of changes in capsid antigen concentration/infectivity
titers in the host cell cultures (viz., as determined by qEIA sig-
nal intensities) were performed spectrophotometrically (Genesys
20 spectrophotometer). Comparative testing of GH and EGCG
on the loss of RTV infectivity titers was performed as described
above, but the RTV was challenged by varying concentrations
of GH (62.5–5,000 μg/ml) and EGCG (0.19–575 μg/ml) sus-
pended PBS. The suspensions were incubated for a periods of
60min., followed by inoculation of 25μl of each preparation onto
MA-104 cell culture monolayers grown in 96-well ﬂat bottom
microtiter plates. The cells cultures were incubated as described
above. The supernatants were then tested for changes in infec-
tivity titers using the qEIA (see Lipson et al., 2001a). Positive
controls were performed exactly as experimentals, but in the
absence of GH or EGCG. All experiments were performed in
triplicate.
FIGURE 1 | Rapid in vitro determination of rotavirus infectivity.
Rotavirus/flavonoid preparations (and controls) were added in triplicate to
MA-104 grown in 96-well cluster plates. After 5 days, the viral capsid protein
(i.e., VP6) was quantitatively measured by antigen capture enzyme-linked
immunosorbent assay using spectrophotometric readings as the objective
signal standard. Spectrophotometric readings were reported as the
mean ± SE of the means. P-values <0.05 were considered statistically
significant.
Cytotoxicity Testing
Cytotoxicity testing was performed using the ToxilightR Non-
Destructive Cytotoxicity Bioassay kit (Cat. No. LT37-619; Lonza,
Rockville, MD, USA). Testing was performed in 96-well ﬂat
bottom polypropylene cluster plates containing MA-104 cells
grown to monolayer culture, as per manufacturer’s speciﬁca-
tions. The assay is a quantitative measure of cellular (membrane)
damage through the release of adenylate kinase (AK) driving
in part, the classic lucinferin/luciferase assay to aﬀect an ATP
“spark.” Brieﬂy, increasing concentrations of GH and EGCGwere
added to MA-104 culture monolayers and incubated for 48-h at
room temperature (23◦C). Cytotoxicity testing was performed
after the incubation period. The positive control consisted of
an ammonium chloride-based lysing reagent (Lonza). The neg-
ative control consisted of PBS. Readings were reported as relative
light units (RLUs) employing a Modulus luminometer (Turner
Biosystems/Promega Corp., Sunnyvale, CA, USA).
Statistics
All experiments were performed in triplicate. Data points are
reported as the mean ± SE of the means. P-values <0.05 were
deemed statistically signiﬁcant.
Results and Discussion
The continual occurrence of resistant microorganisms through
the selective pressures of antibiotic and antiviral use, remains an
important issue in patient care and management. The success-
ful in vitro and to a lesser number, in vivo application of natural
plant products as antiviral moieties, foster the need for continued
research with selected plant metabolites as alternative medicines,
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supplements, and perhaps structural models for the design of new
therapeutic agents (Nagi et al., 1992; Nance and Shearer, 2003;
Lipson et al., 2010; Jin, 2013).
Alpha-GH, a semisynthetic ﬂavanone extracted from citrus
fruits, was originally manufactured as a cosmetic to improve skin
tone and circulation. More recently, GH was shown eﬀective as
an antiviral, through the blockage of inﬂuenza virus replication
by the inhibition of viral sialidase needed for viral penetration
and egress (Saha et al., 2009). These ﬁndings, coupled with the
product’s extremely high solubility, prompted us to address this
agent’s eﬃcacy against an unrelated infectious virus – the RTV.
Comparative testing using the well-studied and characterized cat-
echin, EGCG of the evergreen plant C. sinensis (viz., used in the
manufacture green tea), was performed as well (Steinmann et al.,
2013).
Direct viral testing of RTV by GH in cell-free suspension
using the qEIA showed a loss of viral capsid antigen/integrity
starting at a GH input concentration of 50–60 × 103 μg/ml.
An increased loss of viral antigen occurred after an incuba-
tion period of 30 rather than 5 min., indicating a temporally
associated eﬀect by the semi-synthetic ﬂavanone upon the viral
capsid protein (Figure 2). The loss of viral antigen by GH more
speciﬁcally, suggests an eﬀect by the semisynthetic ﬂavonoid on
the integrity, or at the very least, the availability of VP6 anti-
gen, most probably denoting an eﬀect by the ﬂavonoid on the
virion’s (inner) capsid protein. It would not be unreasonable to
suggest a ﬂavonoid mediated direct aﬀect on RTV VP6 cap-
sid protein and in turn, a blockage of the particle’s antigenic
determinants’ binding to the EIA capture antibody. Supportive
to this suggestion is our recent work using transmission elec-
tron microscopy, showing an enshrouding or total entrapment
of RTV by soluble and particulate proanthocyanidins (Lipson
et al., 2011, 2012). As similarly recognized among the proan-
thocyanidin group of ﬂavonoids, hesperidin and its aglycone
hesperitin function in part, as protein adsorbents, supporting
our proposed mechanism of GH-associated RTV capsid antigen
FIGURE 2 | Effect of glucosyl hesperidin (GH) on the loss of rotavirus
(RTV) antigen in cell-free suspension. RTV/GH complexes were
maintained for 5 and 30 min. at room temperature (23◦C) followed by the
quantitative measurement (using qEIA) of the VP6 capsid antigen. Data points
from spectrophotometric readings represent the mean ± SE of the means.
P < 0.05 is assumed statistically significant.
loss of activity (see the works by Ding et al., 2012; Chakraborty
et al., 2013; Shen and Lu, 2013). On the organismic level
notably, it is interesting to note that the water soluble trisac-
charide GH retains the same biological activities as its rutinose-
contaning hesperidin glycoside core molecule (Yamada et al.,
2006).
Application of the cell-free assay system as performed herein,
although indicative of the semisynthetic ﬂavonoid’s eﬀect on
VP6 binding to its complementary antibody, limits our inter-
pretation of these ﬁndings to that which is taking place at the
ﬂavonoid-virus interface. Antigen detection (e.g., useful in the
identiﬁcation of protein transport, binding, etc.) is indeed impor-
tant in viral studies. However, and in complement to our use
of the qEIA to detect RTV capsid antigen binding in cell-free
suspension per se, comparative infectivity titer determination
was performed to place a substantive argument for the potential
application (or lack thereof) of GH as an antivirus (anti-RTV)
moiety on the cellular level. Accordingly, testing was performed
to determine the eﬀect of GH on the “growth” (i.e., changes
of infectivity titer over time) of RTV in MA-104 host cells.
Further comparative testing using the well-studied and char-
acterized green tea extract EGCG of Camellia senensis where
appropriate, was evaluated on the cellular level as well. The
latter eﬀort was achieved using Ag-CCA, originally developed
parenthetically, to ﬁll the void for a rapid viral diagnostic tech-
nique in the biomedical setting. The basic concept of Ag-CCA
as an infectivity titration assay (viz., the replication of virus
in host cell cultures followed by conﬁrmatory/quantitative viral
antigen detection (Figure 1), has been well described and exten-
sively evaluated employing such techniques as end point titration
[tissue culture infectious dose -ﬁfty (TCID50), immunoﬂuores-
cence, immunoperoxidase, polymerase chain, and other substan-
tive assay systems (Vacquier and Cardiﬀ, 1979; Michalski et al.,
1986; Swenson and Kaplan, 1987; Cowley et al., 1992; Lipson
et al., 2001b; Perez-Ruiz et al., 2003; Terletskaia-Ladwig et al.,
2008).
Among GH-treated RTV particles, infectivity titration testing
showed a lag in viral growth some 24–48 h post inoculation (p.i.;
Figure 3). These observations may simply be ascribed to a viral
eclipse (Shors, 2009). After 72 and 96-h p.i., however, signiﬁcant
diﬀerences in infectivity titers between experimental and control
systems were recognized. One-hundred× 103 μg/ml GH aﬀected
a loss of RTV infectivity to approximately 75 and 85% of control
at 3 and 4 days p.i., respectively, with GH appearing slightly less
eﬀective at the lower viral input concentration (viz., 3.1 × 103
vs. 3.1 × 104 TCID50/ml; Figure 3). Such diﬀerences in infectiv-
ity titers, i.e., as measured by viral growth (or more appropriately
termed, viral replication), may be explained by those diﬀerences
in the experiment’s input viral concentrations. In accord with that
deﬁned by the Poisson distribution, an increase in viral input
concentration, viz., the ratio of viral particles to the host cell
population or multiplicity of infection would reﬂect an increase
the number of cells infected in a given assay system (Racaniello,
2011). Viral yield accordingly, would be reﬂected by respective
changes in infectivity titers over time.
Anti-RTV activity appeared to be reduced some 120-h (5 days)
p.i. (Figure 3), suggesting that GH inhibitory activity wanes with
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FIGURE 3 | Effect of GH (100 × 103 μg/ml) on the isolation [antigen
detection-cell culture amplification (Ag-CCA)] of RTV in MA-104 cell
culture monolayers. Input titers: 3.1 × 103 to 3.1 × 104 TCID50/ml. Day 2
experimental (3.1 × 104) vs. Positive control (3.1 × 104 TCID50/ml): p = 0.08
(n = 3). Spectrophotometric readings performed at 450 nm. Data points
represent the mean ± SE of the mean. P < 0.05 was assumed statistically
significant.
FIGURE 4 | Loss of rotavirus (RTV) infectivity following treatment with
glucosyl hesperidin and epigallocatechin gallate (EGCG). A markedly
reduced concentration of EGCG was effective in reducing RTV infectivity by 1
log10. Virus treatment with glucosyl hesperidin failed to approach that of
EGCG, regardless of using the inordinately high flavanone concentration of
5000 μg/ml. Mean ± SE of the mean. P < 0.05 was assumed statistically
significant.
time. This suggestion is supported by the known stability (or
instability) of GH, whereby the semisynthetic ﬂavanone in ques-
tion readily hydrolyzes to its insoluble aglycone state (Hijiya and
Miyake, 1999); One may not rule out a change in GH solubility
thereby reducing the molecule’s dispersion in cell culture and in
turn, a reduction in the ﬂavanone’s eﬀect.
Several commercially available secondary plant metabolites
showed antiviral activity to the wild type RTV Wa (human)
strain in MA-104 cells cultures. The ﬂavanone hesperidin and the
ﬂavone diosmin (a semsynthetic modiﬁed hesperidin) displayed
the greatest RTV inhibitory activity at inhibitory concentration-
ﬁfty (IC50) endpoints of 10 μM (ca., 0.006 μg/ml); IC90 or
greater inhibitory values were not determined (Bae et al., 2000).
The antiviral eﬀect was ascribed to the rutinose (6-O-α-L-
rhamnosyl-D-glucose) “R” group moiety of each ﬂavonoid in
FIGURE 5 | Effect of EGCG on RTV infectivity in MA-104 host cell
cultures. RTV was treated with increasing concentrations of EGCG,
incubated in suspension for 60 min., followed by inoculation of 25 μl of the
virus-catechin complex into microtiter plates (96-well cluster plates) containing
MA-104 cells in monolayer culture. After 5 days in culture, viral capsid antigen
levels were quantitatively determined. The appearance (or absence) of the
cytopathic effect (CPE) was recorded as well. Replicate cultures were
monitored for a period of 8 days, showing no differences in the appearance of
the RTV CPE. Data points based on spectrophotometric readings represent
the mean ± SE of the means. P < 0.05 was assumed statistically significant.
160 vs. 320 μg/ml: P = 0.24. Insert A Photomicrograph of the RTV CPE
shows a breakage of cell monolayer with the appearance of cellular rounding
and clumping (see Lipson, 1992). Mock infected cell cultures remained intact
for the duration of the experiment (not shown).
FIGURE 6 | Cytotoxicity testing of glucosyl hesperidin and
epigallogatechin gallate MA-104 cell cultures. Cytotoxicity testing
employed the “ToxilightR Non-Destructive Cytotoxicity Assay”. Readings were
performed using a Modulus luminometer (Turner Biosystems/Promega Corp.,
Sunnyvale, CA, USA) with data presented as relative light units (RLUs). Data
points represent the mean ± SE of the means. P < 0.05 were assumed
statistically significant.
question, with monolayer pre-treatment showing the greatest
inhibitory eﬀect. The anti-RTV eﬀect shown by Kim and co-
workers (Bae et al., 2000) however, may not be considered
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FIGURE 7 | Selected flavanones reported to possess antiviral activity. (A) Hesperidin, a flavanone glycoside; (B) hesperitin, an aglycone of hesperidin;
(C) α-glucosyl hesperidin (A semi-synthetic derivative of hesperidin. U.S. Patent number: 5,652,124); (D) EGCG.
indicative of a hesperidin-associated broad-scale antiviral activ-
ity, as suggested by a paucity of such hesperidin-virus studies
within the last 10 or more years. The extremely low solu-
bility of hesperidin in water (viz., <0.01%) and the need to
use obfuscating organic carrier molecules to bring the hes-
peridin molecule into solution, has been suggested to be a lim-
iting factor in the use of this ﬂavonoid in antiviral research
(Saha et al., 2009). Paredes et al. (2003) notwithstanding, did
address the potential antiviral activity of hesperidin as well as
the related naringin (glycosides of the aglycones hesperitin and
naringenin), showing no inhibitory activity on a Sindbis virus
neurovirulent strain used as a test system. The recent work by
Lipson et al. (2013) albeit through quantitative viral antigen test-
ing, showed no direct eﬀect by hesperidin, diosmin, nor the
ﬂavonone naringin, on the RTV strain SA-11. In the current
study, use of the highly soluble GH interestingly, necessitated
inordinately high concentrations to approach that antiviral activ-
ity shown by Bae et al. (2000) using the naturally occurring
(rutinose-containing) hesperidin plant metabolite. These ﬁnd-
ings, perhaps initially viewed as contradictory, may actually be
ascribed to small variations (viz., disaccharide vs. trisaccharide
“R” groups on the hesperidin molecule) and/or the recognition
of viral strain diﬀerences (viz., the human Wa vs. the primate
RTV SA-11 strains) between RTV particles under investigation.
Similarly, small structural changes between numerous ﬂavonoid
types has been recently shown to signiﬁcantly aﬀect the extent
of antiviral (canine distemper virus) activity in Vero host cell
cultures (Carvalho et al., 2013). It is also interesting to note
that the marked solubility of GH apparently had no signiﬁcant
eﬀect on reducing the semisynthetic ﬂavanone’s high concentra-
tions necessary to invoke an anti-RTV response in the virion’s
host cell.
FIGURE 8 | Effect of EGCG on MA-104 cell cultures. (A) Three hundred
microgram EGCG induces a precipitation effect in microtitier wells containing
MA-104 cell cultures maintaned in minimal essential medium plus
supplements. (B) Untreated MA-104 monolayer culture. Amino acids and
proteins are known to bond onto EGCG in a stacking pattern to which the
above effect may be ascribed in (see text for details).
Broad generalities [except perhaps with EGCG (see below) and
to a lesser extent, the proanthocyanidins] in ﬂavonoid antiviral
studies must be made with caution. As seen in the works of others
and in the current investigation speciﬁcally, variables including
diﬀerences in sugar structures, viz., the disaccharide rutinose “R”
group of hesperidin vs. the trisaccharide “R” group on GH (Bae
et al., 2000; Saha et al., 2009; Anonymous, 2010; Schubert et al.,
2010), diﬀerences in the type of carrier molecule (e.g., DMSO,
methanol, ethanol) necessary to bring immiscible ﬂavonoids into
solution (Paredes et al., 2003; Lipson et al., 2013), and the use of
diﬀerent virus groups or strains utilized in a given experimental
system (Su et al., 2010; Jin, 2013), make it diﬃcult to generalize
on the antiviral eﬃcacy of most ﬂavonoid types.
Health promoting activities by EGCG, the major cate-
chin of green tea, places this molecule in the forefront of
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ﬂavonoid research. EGCG indeed remains one of the most
studied natural plant products of the last one or two decades
(Jin, 2013). Green tea consumption and the experimental
use of EGCG both in vitro and in the animal model, have
shown these products to possess anti-cancer, anti-obesity, anti-
atherosclerotic, anti-diabetic, as well as anti-microbial activ-
ity (Suzuki et al., 2012). EGCG has also been shown to
possess marked broad scale antiviral activity as well, among
such unrelated viral species/groups as the Human immun-
odeﬁciency virus type I, the Human T-cell lymphotrophic
virus type I, Hepatitis B and C viruses, Herpes simplex virus
types 1 and 2, the Epstein-Barr virus, Human Papilloma
virus, Inﬂuenza virus, rotavirus, and several enterovirus strains
(Mukoyama et al., 1991; Yamaguchi et al., 2002; Bharti
et al., 2009; Jin, 2013; Lipson et al., 2013; Steinmann et al.,
2013). These ﬁndings prompted us to evaluate in parallel,
the broadly eﬀective EGCG green tea extract with the rela-
tively new GH. The purpose of such testing was dual, not
only to simultaneously compare rotavirus loss of infectivity
by each plant extract/semisynthetic product in cell culture,
but to re-conﬁrm the eﬃcacy of our quantitative Ag-CCA
infectivity titer assay as performed in the current research
setting.
Loss of RTV infectivity titers in host cell cultures was minimal
3 days p.i. following inoculation of monolayers with GH/RTV
solutions at GH concentrations ranging from 0.063 to 5 mg/ml.
However, under identical treatment conditions, but using
0.58 mg/ml, EGCG reduced RTV infectivity titers by greater
than one order of magnitude (i.e., > 90%; Figure 4). These
ﬁndings not only denote the validity of our infectivity titra-
tion assay in a comparative evaluation setting, but again point
out the relative superiority of EGCG as an antiviral plant
product.
Dose response curves showed a loss of RTV infectivity
titer by EGCG to approximately 70 to 80% at concentrations
ranging from 160 to 320 μg/ml; No signiﬁcant diﬀerences in
anti-RTV activity between 160 and 320 μg EGCG was rec-
ognized (P = 0.24). A CPE was not recognized by treatment
of monolayer cultures with EGCG concentrations >40 μg/ml
(Figure 5). These values approximated our earlier ﬁndings of
VP6 loss of activity in cell-free suspension (Lipson et al., 2013).
As shown in the current work and that presented by others,
EGCG remains a highly eﬀective antiviral natural plant prod-
uct. The EGCG not only displays consistent antiviral activ-
ity among numerous unrelated viral genera or groups, but
achieves this eﬀect at reduced concentrations. For example,
concentrations ranging from 23 to 46 μM (10.5 to 21 μg
EGCG/ml ) readily inhibit infectivity titers from>1 to 3 log10
(>90–99.9%) among such unrelated infectious agents as her-
pes simplex virus, hepatitis C virus, or enterovirus 71 (Isaacs
et al., 2008; Ho et al., 2009; Calland et al., 2012). We wish
to point out that inaccurate or obfuscating RTV infectivity
titer levels due to possible GH- or EGCG-associated cytotox-
icity, was non-existent in the current work (Figure 6). GH
and EGCG at concentrations ranging from 6.2 to 200 mg/ml
and 0.18 to 0.6 mg/ml, respectively, (ranges encompassing
that used in the present study), failed to produce any gross
cell morphologic changes or alterations of host cell membrane
integrity.
Basic structural diﬀerences between naturally occurring
ﬂavonoids and the semisynthetic GH, as depicted on Figure 7,
are suggested to be signiﬁcant factors in one’s analysis of such
natural plant products’ antiviral eﬀects. The importance of
ﬂavonoid structural disparities were most clearly exempliﬁed
through comparative testing of four related catechin subgroups,
wherein antiviral activity was shown to be related to the extent
of molecule hydroxylation and the presence or absence of gal-
loylation at the ﬂavan-3-ol’s B and C rings, respectively, (Song
et al., 2005; Gescher et al., 2011; Lipson et al., 2013). As alluded
to above moreover, diﬀerences in antiviral activity to diﬀerent
viral species by the same ﬂavonoid, occur as well. We suggest
that no one secondary plant metabolite nor virus per se, may
serve as an indicator or model system to the myriad of infec-
tious agents circulating ad perpetuity throughout the world’s
populations.
Increased concentrations of EGCG (ca., 300 μg/ml), observed
under light microscopy, were observed to form particulate-
like aggregates within cluster plate wells containing MA-104
cells maintained in culture medium (Figure 8). We ascribe
this eﬀect to an aﬃnity by EGCG to constituent amino acids
and perhaps low molecular weight proteins present in the
system’s cell culture medium. EGCG is indeed known to
bind to numerous amino acid and protein types (Ricardo-
da-Silva et al., 1991; Charlton et al., 2002; Pascal et al.,
2007). The addition of FBS to such a deﬁned medium fur-
ther adds to the plethora of amino acids and proteins in
the pabulum used for cell growth and maintenance (Freshney,
2010). It is interesting to note that elevated concentrations
of EGCG or GH failed to produce any cytotoxic eﬀects
in the current system (Figure 6). These ﬁndings proba-
bly reﬂect a binding of EGCG to amino acids or protein
components present in the system’s culture medium, with
MA-104 monolayers apparently refractory to potentially cyto-
toxic eﬀects incurred by the ﬂavonoid in question. A sim-
ilar eﬀect did not occur in our cell culture assay system
using GH.
Conclusion
Diﬀerences in GH and EGCG molecule structure appeared to
signiﬁcantly aﬀect these ﬂavonoid’s anti-RTV activity. Molecule
solubility (obviating the need for potentially confounding organic
carrier molecules) is important, but appears subordinate to
ﬂavonoid structure per se. Anti-RTV activity by EGCG was sig-
niﬁcantly more eﬀective than GH, wherein the latter required
inordinately high concentrations to aﬀect a loss of viral infectiv-
ity to >1 log10. Cytotoxicity testing showed no loss of cellular
integrity following monolayer treatment with either EGCG or
GH. The precise mechanism(s) of ECGCor GH anti-RTV activity
is ill deﬁned. However, inasmuch as both EGCG and GH dis-
play amino acid/protein binding activity (Charlton et al., 2002;
Jöbstl et al., 2004; Wang et al., 2007), one might suggest a
binding of the virus in suspension by either ﬂavonoid, aﬀecting
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a blockage of capsid epitopes and in turn, reduced virus detec-
tion. Alternatively, one may not rule out a ﬂavonoid-associated
event taking place on the cellular level. Further studies are needed
on the molecular level to identify whether EGCG, GH, or other
ﬂavonoid groups aﬀect a down regulation of cellular protein syn-
thesis which in turn, might compromise one or more stages in the
RTV replication cycle.
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